Truist Financial Corp Acadia Pharmaceuticals Inc Transaction History
Truist Financial Corp
- $66.7 Billion
- Q2 2025
A detailed history of Truist Financial Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 36,841 shares of ACAD stock, worth $795,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,841
Previous 39,315
6.29%
Holding current value
$795,397
Previous $653,000
21.59%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ACAD
# of Institutions
346Shares Held
165MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$926 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$330 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$260 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$194 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$133 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.49B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...